These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

94 related articles for article (PubMed ID: 21160225)

  • 21. Gastroesophageal reflux disease.
    Fernández-Fernández FJ
    N Engl J Med; 2009 Feb; 360(7):729; author reply 729-30. PubMed ID: 19222130
    [No Abstract]   [Full Text] [Related]  

  • 22. Was it really an "ugly" meta-analysis?
    Fuccio L; Eusebi LH; Bazzoli F
    Am J Gastroenterol; 2009 Nov; 104(11):2853; author reply 2853-4. PubMed ID: 19888243
    [No Abstract]   [Full Text] [Related]  

  • 23. Can proton pump inhibitors be used as bactericidal drugs in Helicobacter pylori-positive patients?
    Saito N; Sato F; Oda H; Takeda H; Kato M; Sugiyama T; Rani A; Asaka M
    Helicobacter; 1999 Sep; 4(3):211-2. PubMed ID: 10469196
    [No Abstract]   [Full Text] [Related]  

  • 24. [What is currently the Helicobacter pylori eradication therapy of choice? Triple therapy (PPI, amoxicillin and clarithromycin) or sequential therapy (PPI and amoxicillin for 5 days followed by PPI, clarithromycin and metronidazole for a further 5 days)?].
    Sánchez-Delgado J
    Gastroenterol Hepatol; 2009 Jan; 32(1):68-9. PubMed ID: 19174106
    [No Abstract]   [Full Text] [Related]  

  • 25. [Effectiveness and safety of proton pump inhibitor and levofloxacin based first-line triple therapy in the eradication of Helicobacter pylori: a meta-analysis].
    Zhang ZF; Zhao G; Liu LN
    Zhonghua Yi Xue Za Zhi; 2008 Oct; 88(38):2722-5. PubMed ID: 19080698
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Helicobacter pylori resistance].
    Alimoradi J; Rasmussen L; Andersen LP
    Ugeskr Laeger; 2010 May; 172(20):1516-21. PubMed ID: 20483098
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Evidence that the degree and duration of acid suppression are related to Helicobacter pylori eradication by triple therapy.
    Sugimoto M; Furuta T; Shirai N; Kodaira C; Nishino M; Ikuma M; Ishizaki T; Hishida A
    Helicobacter; 2007 Aug; 12(4):317-23. PubMed ID: 17669104
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Treatment of Helicobacter pylori infection.
    Miehlke S; Bayerdörffer E; Graham DY
    Semin Gastrointest Dis; 2001 Jul; 12(3):167-79. PubMed ID: 11478749
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Meta-analysis: the influence of pre-treatment with a proton pump inhibitor on Helicobacter pylori eradication.
    Janssen MJ; Laheij RJ; de Boer WA; Jansen JB
    Aliment Pharmacol Ther; 2005 Feb; 21(4):341-5. PubMed ID: 15709984
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Proton pump inhibitors and long-term risk of recurrent upper gastrointestinal bleeding.
    Hsu YC; Lin HJ
    Aliment Pharmacol Ther; 2009 Jan; 29(2):232-3. PubMed ID: 20738263
    [No Abstract]   [Full Text] [Related]  

  • 31. Therapy and drug resistance in Helicobacter pylori infection.
    Bazzoli F; Olivieri L; De Luca L; Pozzato P; Lehours P; Mégraud F
    Dig Liver Dis; 2000 Dec; 32 Suppl 3():S207-10. PubMed ID: 11245297
    [No Abstract]   [Full Text] [Related]  

  • 32. [Should Helicobacter pylori infection be treated prior to long-term proton pump inhibitor therapy?].
    Gisbert JP; Pajares JM
    Med Clin (Barc); 2001 Dec; 117(20):793-7. PubMed ID: 11784512
    [No Abstract]   [Full Text] [Related]  

  • 33. [Acid-related diseases: are higher doses of proton pump inhibitors more effective in the treatment of Helicobacter pylori infection?].
    Villoria A
    Gastroenterol Hepatol; 2008 Oct; 31(8):546-7. PubMed ID: 18928760
    [No Abstract]   [Full Text] [Related]  

  • 34. Non-peer-reviewed data, effect measures, and meta-regression analysis on proton pump inhibitor use and COVID-19.
    Wu DN; Jiao LR; Li GF; Yu G
    Eur J Clin Pharmacol; 2022 Aug; 78(8):1351-1352. PubMed ID: 35575912
    [No Abstract]   [Full Text] [Related]  

  • 35. Helicobacter pylori infection and serum adiponectin.
    Polyzos SA; Kountouras J; Zavos C; Pyrrou N; Tantsi N
    Helicobacter; 2013 Aug; 18(4):321-2. PubMed ID: 23621867
    [No Abstract]   [Full Text] [Related]  

  • 36. Synergic effect of quinolone antibacterial agents and proton pump inhibitors on Helicobacter pylori.
    Tanaka M; Isogai E; Isogai H; Hayashi S; Hirose K; Kimura K; Sugiyama T; Sato K
    J Antimicrob Chemother; 2002 Jun; 49(6):1039-40. PubMed ID: 12039901
    [No Abstract]   [Full Text] [Related]  

  • 37. Proton Pump Inhibitor Therapy and Dementia: What Is the Evidence?
    Yang YX
    J Am Geriatr Soc; 2018 Feb; 66(2):224-226. PubMed ID: 29134626
    [No Abstract]   [Full Text] [Related]  

  • 38. Helicobacter pylori infection and hypertension in end-stage renal disease.
    Sugimoto M; Yamaoka Y
    Kidney Int; 2009 Jun; 75(11):1235. PubMed ID: 19444271
    [No Abstract]   [Full Text] [Related]  

  • 39. Empirical Proton Pump Inhibitor Therapy in Children.
    Prager JD
    JAMA Otolaryngol Head Neck Surg; 2018 Dec; 144(12):1124-1125. PubMed ID: 30325988
    [No Abstract]   [Full Text] [Related]  

  • 40. A Proton Pump Inhibitor a Day Keeps the Iron Away.
    Handa P; Kowdley KV
    Clin Gastroenterol Hepatol; 2016 Jan; 14(1):153-5. PubMed ID: 26383698
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.